One discovered the causal link beneath the progression of hepatic carcinoma is the variant of cancer inhibitor genes triggered by the overexpression of apolipoprotein B mRNA-editing enzyme catalytic subunit 2 (APOBEC2) in liver cells. This evidence concerns the gene APOBEC2 and hepatocellular carcinoma.